JP2011509920A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509920A5 JP2011509920A5 JP2010523299A JP2010523299A JP2011509920A5 JP 2011509920 A5 JP2011509920 A5 JP 2011509920A5 JP 2010523299 A JP2010523299 A JP 2010523299A JP 2010523299 A JP2010523299 A JP 2010523299A JP 2011509920 A5 JP2011509920 A5 JP 2011509920A5
- Authority
- JP
- Japan
- Prior art keywords
- rasburicase
- medicament
- prevention
- treatment
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- 229960000424 rasburicase Drugs 0.000 claims 6
- 108010084837 rasburicase Proteins 0.000 claims 6
- 208000028867 ischemia Diseases 0.000 claims 3
- 230000010410 reperfusion Effects 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 208000020446 Cardiac disease Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000019622 heart disease Diseases 0.000 claims 2
- 239000002516 radical scavenger Substances 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 230000003683 cardiac damage Effects 0.000 claims 1
- 238000007675 cardiac surgery Methods 0.000 claims 1
- 210000004351 coronary vessel Anatomy 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 238000013146 percutaneous coronary intervention Methods 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07291072 | 2007-09-05 | ||
| US1524007P | 2007-12-20 | 2007-12-20 | |
| PCT/EP2008/006858 WO2009030373A1 (en) | 2007-09-05 | 2008-08-20 | Use of urate oxidase for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509920A JP2011509920A (ja) | 2011-03-31 |
| JP2011509920A5 true JP2011509920A5 (https=) | 2011-10-06 |
Family
ID=38713162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010523299A Pending JP2011509920A (ja) | 2007-09-05 | 2008-08-20 | 虚血又は再灌流事象によって引き起こされる心臓の障害又は間接的な後遺症の治療又は予防のための尿酸オキシダーゼの使用 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20100266567A1 (https=) |
| EP (1) | EP2197550A1 (https=) |
| JP (1) | JP2011509920A (https=) |
| KR (1) | KR20100053609A (https=) |
| CN (1) | CN101801460A (https=) |
| AR (1) | AR068360A1 (https=) |
| AU (1) | AU2008295145B2 (https=) |
| BR (1) | BRPI0816406A2 (https=) |
| CA (1) | CA2697929A1 (https=) |
| CL (1) | CL2008002623A1 (https=) |
| CO (1) | CO6260090A2 (https=) |
| IL (1) | IL204259A (https=) |
| MA (1) | MA31624B1 (https=) |
| MX (1) | MX2010001976A (https=) |
| MY (1) | MY183770A (https=) |
| NZ (1) | NZ583635A (https=) |
| PA (1) | PA8794801A1 (https=) |
| PE (1) | PE20090642A1 (https=) |
| TW (1) | TW200927929A (https=) |
| UY (1) | UY31320A1 (https=) |
| WO (1) | WO2009030373A1 (https=) |
| ZA (1) | ZA201000774B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114972A (en) * | 1990-07-30 | 1992-05-19 | Tsuyoshi Ohnishi | Synthesis and uses of new ascorbic acid derivatives which have anti-oxidant and anti-cancer activities |
| JP2004517804A (ja) * | 2000-06-28 | 2004-06-17 | メルク・アンド・カンパニー・インコーポレーテッド | 心臓血管病の治療法 |
| AU2003275160A1 (en) * | 2002-09-20 | 2004-04-08 | Oregon Health And Science University | Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuries |
| ES2567634T3 (es) * | 2004-02-09 | 2016-04-25 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina |
| WO2005099758A2 (en) * | 2004-04-17 | 2005-10-27 | The Board Of Trustees The Leland Standford Junior University | Injectable bioartificial tissue matrix |
| US20070197512A1 (en) * | 2006-01-27 | 2007-08-23 | Japan Tobacco Inc. | Carboxylic Acid Compounds and Use Thereof |
-
2008
- 2008-08-20 WO PCT/EP2008/006858 patent/WO2009030373A1/en not_active Ceased
- 2008-08-20 KR KR1020107004878A patent/KR20100053609A/ko not_active Ceased
- 2008-08-20 EP EP08785655A patent/EP2197550A1/en not_active Withdrawn
- 2008-08-20 JP JP2010523299A patent/JP2011509920A/ja active Pending
- 2008-08-20 CA CA2697929A patent/CA2697929A1/en not_active Abandoned
- 2008-08-20 CN CN200880105379A patent/CN101801460A/zh active Pending
- 2008-08-20 AU AU2008295145A patent/AU2008295145B2/en not_active Ceased
- 2008-08-20 BR BRPI0816406A patent/BRPI0816406A2/pt not_active IP Right Cessation
- 2008-08-20 NZ NZ583635A patent/NZ583635A/en not_active IP Right Cessation
- 2008-08-20 MX MX2010001976A patent/MX2010001976A/es active IP Right Grant
- 2008-08-20 MY MYPI2010000585A patent/MY183770A/en unknown
- 2008-09-03 TW TW097133674A patent/TW200927929A/zh unknown
- 2008-09-03 UY UY31320A patent/UY31320A1/es not_active Application Discontinuation
- 2008-09-03 PE PE2008001545A patent/PE20090642A1/es not_active Application Discontinuation
- 2008-09-03 AR ARP080103828A patent/AR068360A1/es not_active Application Discontinuation
- 2008-09-03 PA PA20088794801A patent/PA8794801A1/es unknown
- 2008-09-04 CL CL2008002623A patent/CL2008002623A1/es unknown
-
2010
- 2010-02-02 ZA ZA2010/00774A patent/ZA201000774B/en unknown
- 2010-02-22 MA MA32638A patent/MA31624B1/fr unknown
- 2010-02-24 CO CO10021841A patent/CO6260090A2/es not_active Application Discontinuation
- 2010-03-01 US US12/715,061 patent/US20100266567A1/en not_active Abandoned
- 2010-03-02 IL IL204259A patent/IL204259A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ716245A (en) | Fused benzoxazepinones as ion channel modulators | |
| Butler et al. | Management of the no-reflow phenomenon | |
| JP2015533168A5 (https=) | ||
| JP2010504301A5 (https=) | ||
| NZ715983A (en) | Vasoprotective and cardioprotective antidiabetic therapy | |
| JP2010530001A5 (https=) | ||
| JP2013513621A5 (https=) | ||
| FI3562487T3 (fi) | Metalloentsyymi-inhibiittoriyhdisteitä | |
| NZ600400A (en) | Methods for increasing the stabilization of hypoxia inducible factor-1 alpha | |
| JP2009524695A5 (https=) | ||
| JP2013507408A5 (https=) | ||
| JP2011518833A5 (https=) | ||
| JP2013188439A5 (https=) | ||
| NO20090031L (no) | Isoindolinderivater for behandling av arytmi | |
| PH12012501473A1 (en) | Cycloalkyl-substituted imidazole derivative | |
| WO2009105165A3 (en) | Cardioplegia solution for cardiac surgery | |
| JP2018538367A5 (https=) | ||
| JP2011527994A5 (https=) | ||
| MY180338A (en) | 5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative | |
| WO2015074010A3 (en) | Compositions and methods for cardiac regeneration | |
| AR077018A1 (es) | Un comprimido de dosis fija del antagonista del receptor de la trombina y el clopidogrel. | |
| JP2011509920A5 (https=) | ||
| JP2012520302A5 (https=) | ||
| Nakamura et al. | Lead optimization of 5-amino-6-(2, 2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitor | |
| NO20070147L (no) | Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen |